Bio Path | BPTH - Current Liabilities


Bio Path reported $7.86M in Current Liabilities for its fiscal quarter ending in June of 2025.





Current Liabilities Change Date
Alterity Therapeutics Limited AUD 4.38M 849.82K Jun/2023
Baxter International USD 2.97B 805M Dec/2025
Bio Path USD 7.86M 3.12M Jun/2025
Cipla INR 62.97B 8.13B Sep/2025
Clal Biotechnology ILS 6.66M 3.75M Dec/2023
Compugen USD 20.28M 300K Sep/2025
CSL USD 4.61B 207M Dec/2025
Grifols EUR 2.53B 182.67M Sep/2025
Karyopharm Therapeutics USD 87.16M 12.06M Sep/2025